I am Dr. Yi Dong, an attending physician at Nankai University Affiliated Eye Hospital, specializing in ophthalmology. I hold a Master’s in Ophthalmology from Tianjin Medical University and a Bachelor’s in Clinical Medicine from Youjiang Medical University for Nationalities. Since 2015, I have worked at Nankai University, progressing from resident to attending physician.
My research focuses on corneal injury repair, myopia, and diabetic retinopathy. I currently lead a project on amniotic membrane-derived peptide hydrogel for corneal repair, funded by the Tianjin Health Commission. I have co-authored several impactful papers, including studies on minimally invasive corneal surgery and global myopia trends, often serving as co-first or corresponding author.
Skilled in evidence-based medicine and bibliometrics, I analyze research trends to advance ophthalmic knowledge. My work on intermittent exotropia surgery timing has contributed to optimizing treatment strategies. I am committed to bridging research and clinical practice to improve patient outcomes in eye care.
I am Dr. Yi Dong, an attending physician at Nankai University Affiliated Eye Hospital, specializing in ophthalmology. I hold a Master’s in Ophthalmology from Tianjin Medical University and a Bachelor’s in Clinical Medicine from Youjiang Medical University for Nationalities. Since 2015, I have worked at Nankai University, progressing from resident to attending physician.
My research focuses on corneal injury repair, myopia, and diabetic retinopathy. I currently lead a project on amniotic membrane-derived peptide hydrogel for corneal repair, funded by the Tianjin Health Commission. I have co-authored several impactful papers, including studies on minimally invasive corneal surgery and global myopia trends, often serving as co-first or corresponding author.
Skilled in evidence-based medicine and bibliometrics, I analyze research trends to advance ophthalmic knowledge. My work on intermittent exotropia surgery timing has contributed to optimizing treatment strategies. I am committed to bridging research and clinical practice to improve patient outcomes in eye care.